Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis
Journal of Vascular Surgery · 2026-06 · 83 (6) · 1595-1604
DOI: 10.1016/j.jvs.2026.01.024 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2026-06. Verfasst von Mahmoud B Malas und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA. Electronic address: mmalas@health.ucsd.edu. Hauptthemen laut MEDLINE: Endovascular Procedures, Peripheral Arterial Disease, Vascular Grafting, Ischemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Novo Nordisk Fonden.
Abstract (Originalsprache)
BACKGROUND: Age remains an important factor in decision-making and operative outcomes in patients with chronic limb-threatening ischemia (CLTI). Prior studies have used arbitrary age categories. Our aim is to identify an evidence-based age cutoff to differentiate patient outcomes between open and endovascular therapy (ET) in Best Endovascular vs Best Surgical Therapy in Patients with CLTI. METHODS: The Best Endovascular vs Best Surgical Therapy in Patients with CLTI trial dataset was queried to include all patients who underwent open surgical bypass or ET. Patient age on the day of the index revascularization was identified as a continuous variable. Restricted cubic splines were generated to examine the moderating effect of age on the outcomes of procedure type in cohort 1 (bypass with single-segment saphenous vein [SSGSV] vs ET) and cohort 2 (bypass with an alternative conduit vs ET). Four separate spline models for each cohort were generated corresponding to our outcomes of interest: major amputation (above ankle), all-cause mortality, major adverse limb events (MALE defined as above-ankle amputation or major reintervention), and MALE/death. RESULTS: Our study included 1780 patients with a mean age of 67.2 ± 9.7 years (range, 27.9-94.1 years). In cohort 1, the MALE/death spline model showed a lower hazard for SSGSV compared with ET across all ages; however, the upper limit of the hazard ratio confidence interval approaches 1.0 at age 72. There was no age inflection point identified with regard to mortality. Amputation risk was lower with SSGSV compared with ET up to around the age of 57, beyond which there was no difference between the two treatment modalities. Furthermore, the risk of MALE was consistently lower with SSGSV for patients up to age 83. In contrast, in cohort 2, age was not found to be an effect modifier in revascularization outcomes or survival among patients undergoing bypass with an alternative conduit compared with ET. CONCLUSIONS: In this study, we confirmed that bypass with SSGSV was associated with superior MALE-free survival compared with ET up to the age of 72, beyond which there was no significant difference in outcomes between the two strategies. MALE was significantly higher for ET for patients up to age 83. Patient age was not found to favor one revascularization method over the other if the bypass was performed using an alternative conduit. Further studies are needed to compare the effectiveness of revascularization strategies among older patients with CLTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA. Electronic address: mmalas@health.ucsd.edu.
- Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA.
- Division of Vascular & Endovascular Surgery, Department of Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
- Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA.
- Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, MA.
- Division of Vascular Surgery, University of Florida, Gainesville, FL.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Novo Nordisk Fonden
- National Institutes of Health
Zitieren
APA
Malas, M. B., Hamouda, M., Farber, A., Conte, M. S., Rosenfield, K., Shah, S. K., Robinson, W., Shah, K., Strong, M. B., Doros, G., Parikh, S., Lane, J. S., Koopmann, M. C., Peña, C. S., & Menard, M. T. (2026). Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis. Journal of Vascular Surgery, 83(6), 1595-1604. https://doi.org/10.1016/j.jvs.2026.01.024
Vancouver
Malas MB, Hamouda M, Farber A, Conte MS, Rosenfield K, Shah SK, et al. Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis. Journal of Vascular Surgery. 2026;83(6):1595-1604. doi:10.1016/j.jvs.2026.01.024
BibTeX
@article{Malas2026,
author = {Malas, Mahmoud B and Hamouda, Mohammed and Farber, Alik and Conte, Michael S and Rosenfield, Kenneth and Shah, Samir K and Robinson, William and Shah, Khanjan and Strong, Michael B and Doros, Gheorghe and Parikh, Sahil and Lane, John S and Koopmann, Matthew C and Peña, Constantino S and Menard, Matthew T},
title = {Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis},
journal = {Journal of Vascular Surgery},
year = {2026},
volume = {83},
number = {6},
pages = {1595--1604},
doi = {10.1016/j.jvs.2026.01.024}
}
EUVIMED